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Adult hematopoietic stem/progenitor cell (HSPC) numbers remain stable in the absence of external stressors. After bone marrow (BM) transplant, HSPCs need to expand substantially to repopulate the BM and replenish the peripheral blood cell pool. In this study, we show that a noncanonical Wnt receptor, Frizzled-6 (Fzd6), regulates HSPC expansion and survival in a hematopoietic cellintrinsic manner. Fzd6 deficiency increased the ratio of Flt3 hi multipotent progenitors to CD150 + stem cells in the mouse BM, suggesting defective stem cell maintenance. Competitive transplantation experiments demonstrated that Fzd6 2/2 HSPCs were able to home to the BM but were severely impaired in their capacity to reconstitute a lethally irradiated host. Lack of Fzd6 resulted in a strong activation of caspase-3 and a gradual loss of donor HSPCs and peripheral blood granulocytes. Fzd6 was also necessary for the efficient HSPC expansion during emergency hematopoiesis. Mechanistically, Fzd6 is a negative regulator of Cdc42 clustering in polarized cells. Furthermore, b-catenin-dependent signaling may be disinhibited in Fzd6 2/2 HSPCs. Collectively, our data reveal that Fzd6 has an essential role in HSPC maintenance and survival. Noncanonical Wnt-Fzd6 signaling pathway could thus present an interesting target for promoting HSPC expansion and multilineage hematopoietic recovery after transplant. The Journal of Immunology, 2015, 195: 000-000.
A dult hematopoietic stem/progenitor cells (HSPCs) are maintained in a specialized niche in the bone marrow (BM). Multiple signals from the niche regulate HSPC numbers and their ability to self-renew as well as to differentiate into all blood cell types (1, 2) . Microenvironmental cues also influence the cell-cycle status of HSPCs and modulate stem cell polarity. Polarity has been suggested to maintain the dynamic balance of HSPC pool by regulating the outcome (self-renewal versus differentiation) of HSPC divisions (3) (4) (5) (6) . The molecular mechanisms coordinating the cross-talk between niche-associated signals and HSPC-intrinsic polarity determinants remain unclear.
Wnt signaling is necessary for adult HSPC self-renewal in the BM, but it needs to be tightly regulated (7) (8) (9) : mild increases in b-catenin-dependent signaling enhance HSPC function, whereas stronger signals would favor myeloid expansion to the detriment of stem cell self-renewal. Although noncanonical, b-catenin-independent, Wnt signaling pathways are known to modulate cell polarity, cell motility, and tissue patterning (10) (11) (12) (13) (14) (15) (16) (17) , their role in hematopoietic cells is much less well established. Exogenous Wnt5a has been shown to activate b-catenin-independent signaling in Lin 2 Sca1 + c-Kit hi (LSK) hematopoietic progenitors and to improve HSPC maintenance and function by promoting their quiescence (18) (19) (20) (21) . By contrast, hematopoietic Wnt5a expression is augmented during HSPC aging and decreasing Wnt5a levels in aged HSPCs resulted in the restoration of their polarity and selfrenewal (22) . Wnt4 enhances the expansion of fetal liver LSKs, most notably Flt3 hi LSKs, and improves thymic recovery after irradiation and hematopoietic cell transplant through mechanisms that depend on Jnk2 but do not require b-catenin or its binding partner Tcf1 (23, 24) . Lastly, inhibition of canonical Wnt signaling through the activation of Frizzled (Fzd)-8 and the atypical cadherin Fmi maintained quiescent long-term hematopoietic stem cells (HSCs) in the adult mouse BM (25) . Most polarity genes are expressed in fetal HSPCs (23) ; however, the direct role of most core noncanonical Wnt signaling effectors and planar cell polarity (PCP) have not been addressed in hematopoietic cells.
We recently reported that the receptor Fzd6 was at least partially required for the Wnt4-mediated expansion of fetal liver HSPCs in culture (23) . Furthermore, we observed alterations in the frequency of BM HSPCs in Fzd6 2/2 mice on a mixed C57BL/6 3 129sv
background. Fzd6 expression has been demonstrated in HSPCs and mature blood-forming cells in human and mouse (26) with the strongest expression levels corresponding to more immature cell types (27, 28) . Fzd6 is generally associated with PCP signaling in epithelial cells (10, 11, 13, 14) , and it has been previously proposed to act as a negative regulator of the b-catenin-dependent canonical Wnt pathway (15, 29) . Very little is known about the functional role of Fzd6 signaling in the hematopoietic lineage, except for its being involved in the initiation and progression of chronic lymphocytic leukemia in the Em-TCL1 mouse model (30) .
In this study, we have examined the impact of Fzd6 in the regulation of HSPC function using mice on C57BL/6 background. We report a cell-intrinsic requirement for Fzd6 in competitive short-and long-term hematopoietic reconstitution after irradiation and transplant. We show that Fzd6 deficiency impaired the expansion and survival of HSPCs, resulting in the activation of caspase-3 and inefficient HSPC engraftment in the first week after Institut National de la Recherche Scientifique-Institut Armand-Frappier, Université du Québec, Laval, Quebec H7V 1B7, Canada BM transplant. We further show that Fzd6 is necessary for efficient emergency responses during systemic inflammation. Overall, we demonstrate a crucial role for Fzd6 in HSPC self-renewal and negative regulation of Cdc42/Jnk signaling in the BM and suggest that Fzd6 could be an interesting target for stimulating HSPC expansion in culture or in situ posttransplant.
Materials and Methods
Experimental animals C57BL/6 (B6; CD45.2 + ) and B6.SJL-PtprcaPep3b/BoyJ (Ly5a) (B6.SJL; CD45.1 + ) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice deficient in Frizzled-6 (Fzd6 2/2 ) are described elsewhere (14) and were originally a kind gift from J. Nathans (Johns Hopkins, Baltimore, MD). Fzd6 +/2 mice from mixed C57BL/6 3 129sv background were backcrossed to C57BL/6 for 10 generations and then maintained as Fzd6 +/2 to Fzd6 +/2 intercrosses. Fzd6 2 /2 mice were compared with sex-matched Fzd6 +/+ littermates. For competitive transplant experiments, first-generation progeny from B6.SJL 3 Fzd6 +/+ intercrosses were used as recipients, and their littermates or B6.SJL mice were used as competing donors. For noncompetitive short-term transplants and homing experiments, the recipient mice were B6.SJL. All mice were bred and housed under specific pathogen-free conditions in sterile ventilated racks at the animal facility of Institut National de la Recherche Scientifique-Institut Armand-Frappier (Centre National de Biologie Expérimentale). All procedures were in accordance with the Canadian Council on Animal Care guidelines.
Flow cytometry analysis and cell sorting BM was harvested by flushing tibias and femurs with PBS/0.1% BSA/0.5 mmol EDTA using a 25-gauge needle. To analyze BM HSPCs, the following Abs were used: biotin-conjugated anti-lineage mAbs anti-CD3ε (145-2C11), anti-CD11b (M1/70), anti-CD45/B220 (RA3-6B2), anti-GR1 (RB6-8C5), and anti-Ter119; streptavidin conjugated to BD Horizon-V500 (BD Biosciences, Mississauga, ON, Canada) or FITC (BD Biosciences); PE anti-CD117 (c-Kit, 2B8; BD Biosciences), PE-Cy7 anti-Sca-1 (Ly6A/E, D7; BD Biosciences), PerCP-eFluor 710 anti-CD135 (Flt3, A2F10), and Alexa Fluor 647 anti-CD150 (TC15-12F12.2; BD Biosciences). PE-Cy7 anti-CD3, PE anti-CD19 (1D3), allophycocyanin or FITC anti-CD45.1 (A20), eFluor 450 or FITC anti-CD45.2 (104), and allophycocyanin-Cy7 anti-GR1 (BD Biosciences) were used for the analysis of peripheral blood chimerism. For intracellular staining, surfacestained BM cells were fixed and permeabilized using the Foxp3 staining kit (eBioscience, San Diego, CA) and then incubated with PE anti-bcatenin (15B8), Alexa Fluor 488 active Caspase-3 (Cell Signaling Technologies), PE-eFluor 610 anti-Ki67 (SoIA15), PE anti-p-JNK1/2 (pT183/ pY185; BD Biosciences), unconjugated anti-active b-catenin (D13A1; Cell Signaling Technologies), unconjugated anti-Celsr1 (Abcam), or appropriate isotype controls. Unconjugated Abs were detected with a PEconjugated F(ab9) 2 fragment against rabbit IgG (Molecular Probes). All Abs were purchased from eBioscience unless indicated otherwise. For cellcycle analysis, BM cells were first incubated for 30 min at 37˚C with Hoechst #33342 (Sigma-Aldrich, Oakville, ON, Canada) in DMEM supplemented with 10% Premium FBS (Wisent Bioproducts, St-Bruno, QC, Canada) and 1 mmol HEPES (Life Technologies, Burlington, ON, Canada), followed by staining with surface Abs and intracellular anti-Ki67 as described above. The FluoReporter lacZ Flow Cytometry kit (Life Technologies) was used for the detection of b-galactosidase expression from the Fzd6 mutant allele. Samples were acquired with a four-laser LSR Fortessa flow cytometer (BD Biosciences, Mountain View, CA) and analyzed using BD FACS Diva software (BD Biosciences) or FlowJo (for histogram overlays; Tree Star). For cell sorting, BM cells were stained as above. For fetal liver HSCs, CD11b was removed from the lineage panel, and cells were further stained with Alexa Fluor 647 anti-CD150 and PECy7 anti-Sca-1, and allophycocyanin-Alexa Fluor 780 CD11b samples were sorted for purity with a three-laser FACSAria II (BD Biosciences). . Cells were washed in PBS, fixed, and permeabilized at 4˚C for 90 min, washed, and blocked with 3% BSA for 30 min, followed by staining with anti-Cdc42 (EMD Millipore) for 1 h. Staining was detected with a PE-conjugated F(ab9) 2 fragment of goat anti-rabbit IgG (Molecular Probes) in blocking buffer for 1 h. Cells were counterstained with DAPI (Life Technologies). Stained cells were washed in PBS and acquired with Amnis Imagestream Mark II imaging flow cytometer (EMD Millipore) and analyzed with IDEAS v6.1 software. A cell was considered polarized when Cdc42 protein showed a distinctly asymmetrical distribution when a line was drawn across the middle of the cell.
Colony assays
Single-cell suspensions were prepared in IMDM containing 10% Premium FBS (Wisent Bioproducts), and cells were seeded into 35-mm nonadherent petri dishes at a density of 10 4 cells/dish in methylcellulose medium containing stem cell factor, IL-3, IL-6, and erythropoietin (Methocult GF M3434; Stem Cell Technologies). The cultures were incubated at 37˚C in 5% CO 2 for 7-10 d, and hematopoietic colonies were counted and identified based on morphology under an inverted microscope. Harvested colony-forming cells were further stained with Abs against CD11b, CD11c, CD117/c-Kit, GR1, CD45.1 and CD45.2. Stained cells were analyzed as described above. ) of total BM cells from two primary recipients were pooled and injected into lethally irradiated secondary recipients. For short-term analysis, 10 3 10 6 donor cells were transferred without competition. To determine peripheral blood chimerism, blood samples were collected through the mandibular vein from recipient mice at 4, 8, 12, and 16 wk and analyzed by flow cytometry. Sixteen weeks after transplantation, mice were euthanized and analyzed for reconstitution in BM and spleen.
Transplantation assays

Homing assay
To determine the homing efficiency of hematopoietic cells, 20 
Emergency hematopoiesis
To evaluate HSPC expansion during emergency hematopoiesis, Fzd6
2/2
and Fzd6 +/+ mice were given two i.p. injections of g-irradiated LPS (E. coli 0111:B4; Sigma-Aldrich) at a dose of 1 mg/kg body weight, 48 h apart (31) . Their BM was harvested 24 h after the second injection for flow cytometry and functional analysis.
Statistical analysis
Each value represents at least three independent experiments. Two-tailed Student t test was used to determine statistical significance unless otherwise noted. A p value ,0.05 was considered significant.
Results
Fzd6 deficiency does not affect intracellular b-catenin levels in HSPCs
Fzd6 mRNA is abundantly expressed by fetal liver (23) as well as BM HSPCs (28) . However, given the different methods of detection and the variable markers used for cell identification, we wanted to validate these results and directly compare Fzd6 expression levels in fetal liver and adult mouse BM CD150 + LSK cells, which are enriched in HSCs (32) , as well as different HSPC subpopulations in the BM. Fzd6 mRNA levels were comparable between adult and fetal liver CD150 + HSPCs as detected by quantitative RT-PCR on sorted cells (Fig. 1A) . To evaluate Fzd6 expression in different BM HSPC subpopulations, we took advantage of the LacZ construct inserted into the Fzd6 mutant allele (14) . Using fluorescein di-V-galactoside as the substrate for b-galactosidase, only CD150 + HSPCs displayed detectable levels of Fzd6 promoter activity (Fig. 1B) . These results correlate well with previously published data (28) as well as data found in the Immunological Genome project database (26) (http://www.immgen. org) and support the hypothesis that Fzd6 play a key role in the regulation of fetal and adult hematopoiesis.
Fzd6 has been associated with noncanonical Wnt signaling (13, 14) with the potential to inhibit b-catenin-dependent canonical Wnt pathway in nonhematopoietic cells (15, 29) . In contrast, Fzd6 expression correlated with increased levels of intracellular bcatenin in a mouse model of chronic B lymphocytic leukemia although there was no evidence of a direct functional relationship (30) . To determine whether lack of Fzd6 modulated b-catenin in normal BM HSPCs, we quantified intracellular active b-catenin levels by flow cytometry using an Ab specific for the stable, nonphosphorylated form of the protein. We observed no difference in b-catenin staining between Fzd6 +/+ and Fzd6 2/2 CD150 + HSPCs (Fig. 1C) , indicating that Fzd6 was not involved in the maintenance of intracellular b-catenin levels in HSPCs at steady state and thus appeared to signal through a noncanonical pathway.
Fzd6 has an age-dependent effect on hematopoietic progenitor cell maintenance LMPPs. Representative flow cytometry data are shown for 6-wk-old Fzd6 2/2 and Fzd6 +/+ BM. Numbers within the flow cytometry panels represent the mean percentages of total LSKs as well as the different LSK subsets over total LSKs from eight animals per group. Histogram represents the absolute numbers of BM LSK subpopulations HSC, MPP, and LMPP in 3-wk (n = 6) and 6-wk-old (n = 8) Fzd6 2/2 and Fzd6 +/+ mice (mean + SEM). (E) Cell-cycle analysis of CD150 + HSCs. Ki-67/Hoechst costaining was used to distinguish the G 0 , G 1 , and S/G 2 /M cell cycle phases. Histogram represents mean + SEM from three animals per group. *p , 0.05, **p , 0.005 (two-tailed, unpaired Student t test). (Fig. 1D) . This was largely due to an overall increase in Flt3 staining intensity in Fzd6 2/2 BM, suggesting defective HSC maintenance. Given that a relative increase in more differentiated, Flt3 + subsets could correlate with HSC activation (25, 33, 34) , our observation led us to speculate that Fzd6 might be involved in the regulation of HSC turnover.
During resting hematopoiesis, the majority of long-term HSCs remain in a quiescent state with only a small fraction that are actively cycling. Adult HSC self-renewal has been frequently linked to HSC quiescence because disruption of quiescence leads to defects in HSC self-renewal (25, (34) (35) (36) . More specifically, noncanonical Wnt5a signaling favors HSC maintenance via quiescence (19, 21, 25) (Fig. 1E) . However, we did observe a slight but reproducible decline in the proportion of dividing (S-G 2 -M phase) Fzd6 2/2 HSCs (Fig. 1E) 
Fzd6
+/+ mice (Supplemental Fig. 1 ). Our data therefore indicate that Fzd6 deficiency increases the ratio of Flt3 hi LMPPs to CD150 + HSCs within the LSK compartment (Fig. 1D ), but the potential lymphoid bias appears compensated for during steadystate hematopoiesis.
Fzd6 negatively regulates Cdc42/JNK signaling in HSPCs
Noncanonical Wnt signaling can modulate cell divisions (11, 12) , HSPC quiescence (19, 21, 25) , and polarity (22) . In particular, an increase in Wnt5a/Cdc42-dependent signaling has been linked to the apolarization of HSPCs during aging (4, 22) , whereas Fzd8/ Fmi-dependent suppression of HSPC activation is necessary for the maintenance of long-term HSCs (25) . To evaluate the role of Fzd6 in noncanonical signaling, we examined the expression of Celsr1, which has been shown to interact with Fzd6 in other tissues (16), phosphorylated active JNK, and Cdc42 in Fzd6 2/2 and Fzd6 +/+ HSPCs by flow cytometry. We did not observe any difference in Celsr1 expression ( Fig. 2A) , although we cannot conclude about its localization. However, both p-JNK and Cdc42 were present at higher levels in Fzd6 2/2 HSPCs ( Fig. 2A) , suggesting that Fzd6 might negatively regulate Cdc42/JNK signaling. The localization of Cdc42 appears essential for its role in HSPC polarity and aging (22 HSPCs became even more pronounced at 12 and 16 wk (Fig. 3B ) with a progressive loss of Fzd6 2/2 GR1 hi granulocytes, which suggested defective long-term HSC self-renewal (Fig. 3C) . To further determine the cell-intrinsic role of Fzd6 in myelolymphoid (Fig. 3D) . To obtain a more quantitative representation of lymphoid and myeloid lineages, we also analyzed the spleen at 16 wk after transplant. The numbers of Fzd6 2/2 donor-derived cells were significantly decreased for all subsets (Fig. 3D) , with an ∼5-fold difference for B lymphocytes and monocytes and an ∼10-fold decrease for T lymphocytes and granulocytes. Flow cytometry analysis of BM cells from the primary recipient mice confirmed the absence of Fzd6 2/2 HSCs in the majority of recipients at 16 wk after transplantation (Fig. 4A) . Consistent with the peripheral blood analysis, in vitro colony-forming ability of myeloid progenitor cells of Fzd6 2/2 origin was also significantly decreased ( Fig. 4B ). To further test the self-renewal activity of donor cells, we selected primary recipients of Fzd6 2/2 BM cells with detectable donor contribution at 16 wk (11-32% total chimerism in peripheral blood) together with representative primary recipients of Fzd6 +/+ cells for secondary transplants. As expected from the frequency of phenotypic donor HSCs (Fig. 4A) , Fzd6 2/2 donor cells were unable to establish multilineage hematopoietic reconstitution (.1% in all lineages) in secondary recipients, even at short-term (Fig. 4C) . In comparison, Fzd6 +/+ donor cells were present in secondary recipients at a frequency that was at least equivalent to that detected in primary recipients (Fig. 4C, 4D ). These data strongly suggest that Fzd6 is crucial for in vivo repopulating activity and HSC self-renewal capacity, particularly under stress.
Long-term reconstitution defects of Fzd6-deficient HSPCs are not due to altered homing but rather to defective survival and expansion in the recipient BM To understand the mechanisms underlying the observed defects in the engraftment and reconstitution capacity of Fzd6 2/2 HSPCs, we first examined the role of Fzd6 in BM homing. To assess the homing efficiency of HSPCs, Fzd6 2/2 or Fzd6 +/+ BM cells were transplanted into sublethally irradiated congenic recipient mice, and the numbers of donor-derived HSPCs in the BM were determined by flow cytometry at 16 h (Fig. 5A) . Our results revealed no differences in the ability of Fzd6 2/2 cells to home to the BM when compared with Fzd6 +/+ controls (Fig. 5B) . Furthermore, the percentage of donor-derived granulocytes generated in a colonyforming assay was similar for both Fzd6 +/+ and Fzd6 2/2 donors (Fig. 5C ). Not surprisingly, we saw no major differences in the expression levels of Cxcr4 or CD44 between Fzd6 +/+ and Fzd6
2/2
HSPCs at baseline (Fig. 5D) . These results indicate that the presence of Fzd6 is not necessary for migration to the BM. It might rather be required for HSPC expansion and maintenance. Given the problems with myeloid reconstitution already present at 4 wk posttransplant (Fig. 3C) , we hypothesized that the loss of Fzd6 2/2 donor HSPCs would be an early event. We therefore decided to investigate the initial HSPC expansion to repopulate the recipient BM at 4 and 8 d posttransplant (Fig. 6A) . Fzd6 2/2 HSPCs were present at comparable numbers on day 4 but failed to expand between days 4 and 8 (Fig. 6B) . Cell-cycle analysis correlated with cell numbers, with the proportion of Fzd6 +/+ donor cells in the proliferating phase increasing between the two time points in contrast to Fzd6 2/2 HSPCs (Fig. 6D ). Fzd6 2/2 cells showed similar behavior in both noncompetitive (Fig. 6 ) and competitive settings (Figs. 3, 4) , suggesting a decrease in not only relative Fzd6
HSPC fitness but also in absolute terms. These results parallel the cell cycle analysis at steady state (Fig. 1E) , suggesting that either: 1) Fzd6 is directly implicated in cell-cycle progression; or that 2) dividing Fzd6 2/2 HSPCs are lost due to differentiation or cell death.
To investigate the second possibility, we stained posttransplant BM cells with an Ab against the active form of caspase-3 together with b-catenin. Sustained b-catenin expression has been shown to activate caspase-3 and result in loss of HSPCs shortly after transplant (38) cKit + cells, which are indicative of colony-forming cells with high proliferative potential (Fig. 6F) , suggesting that a larger proportion of the remaining Fzd6 2/2 HSPCs had initiated myeloid differentiation. In contrast to steady-state, we did not observe any difference in p-JNK activity (Fig. 6C) . Collectively with the data presented in Fig. 5 , these results clearly demonstrate that Fzd6
HSPCs are fully able to reach the BM, but, once at destination, fail to expand due to a strong activation of caspase-3 and consequently decreased HSPC survival.
Fzd6-deficient HSPCs expand poorly in response to emergency signals
To determine if Fzd6 2/2 HSPCs fail to expand also in response to other types of proliferative stress, we induced emergency myelopoiesis using a sublethal dose of LPS (Fig. 7A) HSPCs also generated proportionately fewer c-Kit + cells in a colonyforming assay (Fig. 7D) , similar to what we saw shortly after transplant. Therefore, Fzd6 is necessary for efficient BM HSPC expansion and self-renewal, not only after transplant but also under proliferative stress such as emergency myelopoiesis.
Discussion
We HSPCs were able to reach the recipient BM, they failed to reconstitute an irradiated host due to impaired expansion and survival. Fzd6 2/2 HSPCs also failed to expand in response to LPS. Thus, Fzd6 was necessary for normal HSPC function in a hematopoietic cell-intrinsic manner. Self-renewal is a crucial feature of HSCs, which allows them to replenish all hematopoietic lineages under conditions of BM stress (e.g., ablative chemotherapy, irradiation, infections, and injury) (34, 39, 40) . Wnt signaling can play a critical role in HSPC selfrenewal, although the extent and source of signals are still under debate and likely involve different pathways under different circumstances (22, 25, 41) . Canonical Wnt signaling is induced by myeloablative stress (25) and reportedly required for hematopoietic recovery in response to irradiation (41) . However, in the absence of negative regulators, such as Fzd6 (29) (38, 42, 43) .
Fmi and Fzd8 loss-of-function studies suggested a noncanonical requirement for the maintenance of HSPC quiescence, as their absence altered the pool size, self-renewal, and engraftment of HSPCs (25) . Namely, Fzd8/Fmi signaling axis inhibited canonical Wnt signaling in HSCs and thus maintained HSC quiescence at steady state. Label-retaining HSCs expressed much higher levels of Fzd8 and Fmi than cycling HSCs, and both Fmi and Fzd8 expression was decreased after activation of HSCs in response to 5-fluoro-uracil. Exogenous Wnt5a is also reported to maintain HSCs by enforcing their resting state (19, 21 HSPCs, the enhanced Cdc42 activity could interfere with canonical Wnt signaling in our model and contribute to, for example, decreased cell-cycle progression. In contrast, increased phosphorylation of b-catenin by Jnk could promote the translocation of stable b-catenin to the nucleus and thus enhance the potential for canonical Wnt signaling (47) . Altered engraftment of HSPCs in the BM is frequently associated with impaired homing to the BM niche. This is certainly the case for HSPCs mutated for cell adhesion-related genes, such as Rho-family small GTPases Cdc42 and Rac1 (48, 49) . Although we cannot completely exclude defective interaction of Fzd6
2/2
HSPCs with the recipient stromal cells, we detected no impairment in their ability to home to the BM immediately after transplant. There was also no difference in the expression of CD44, a classical Wnt target gene (45) that is involved in BM homing (50 Taken together, we have shown in this study that Fzd6 plays an essential role in long-term maintenance and self-renewal of mouse HSPCs in a hematopoietic cell-autonomous manner that was likely independent of HSPC homing to the BM but rather related to their expansion, maintenance, and survival. Mechanistically, Fzd6 is a negative regulator of both Cdc42/Jnk and b-catenindependent signaling. We propose that the activation of Fzd6 signaling through pharmacologic means would constitute an interesting option for improving HSPC engraftment and the recovery of immune function after transplant.
